BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CERAM to Present at Medtec Ireland


9/19/2011 10:43:27 AM

19 Sept. 2011 (Stoke-on-Trent, UK) - Ceram, the global materials technology consultancy that focuses on innovation, sustainability and quality, will once again be exhibiting at Medtec Ireland in Cork on 5-6 October.

Ben McCarthy, Technical Consultant at Ceram, will also be speaking at the Conference. His talk, ‘Surface Analysis Comparison of In-vitro Bioactivity Testing’ will focus on how surface analytical techniques can analyse different deposition methods and highlight comparisons between immersion and in-vitro cell testing.

Determined to stay at the forefront of medical materials and technologies innovation, Ceram has recently developed a new series of multi-elements-substituted hydroxyapatites, biomaterials with enhanced performance and different biological properties. New controlled release technologies have also been developed, using bioglasses and bioceramics as carriers for a variety of active ingredients. Ceram now offers client-bespoke formulations for specific applications, including the controlled release of pharmaceutical active compounds and also the enabling of sequential, and time and site well-ordered, delivery of multiple agents.

To find out more, visit Ceram on Stand 209 – www.ceram.com/healthcare



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES